A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma

NCT01839799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Abraxane
DRUG: FOLFIRINOX
RADIATION: Chemoradiation

Sponsor

Abramson Cancer Center at Penn Medicine